This aligns with previous studies demonstrating that tirofiban was not associated with increased ICH risk and showed a trend toward improved functional outcomes [ 17 , 52 , 53 ] .
← all excerpts
Efficacy and safety of adjunctive tirofiban administration in anterior large vessel occlusion due to large artery atherosclerosis: an individual patient data pooled analysis of two randomized clinical trials.
1
—
—